Related references
Note: Only part of the references are listed.Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis A retrospective observational study
Daisuke Waki et al.
MEDICINE (2020)
Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis: results from a longitudinal, matched-cohort data linkage study
Shifa H. Sarica et al.
RHEUMATOLOGY (2020)
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
Andreas Kronbichler et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry
Sabine Jardel et al.
AUTOIMMUNITY REVIEWS (2018)
Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study
Liu Yang et al.
BMC NEPHROLOGY (2018)
Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis
Andreas Kronbichler et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
Remi Goupil et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease
JulieAnne G. McGregor et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Share Paper
